Christina Mattina

Christina Mattina

Christina is the associate editorial director of The American Journal of Managed Care® (AJMC®) and Population Health, Equity & Outcomes, and joined AJMC in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.

She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.

Articles by Christina Mattina

Healthcare attorney James M. Daniel, Jr, JD, MBA, explained how healthcare providers will be impacted by CMS’ newly released final rule on the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) in a session during the second day of the ACO & Emerging Healthcare Delivery Coalition.

HHS has issued its final rule on the Medicare Access and CHIP Reauthorization Act (MACRA), which reforms the Medicare payment system as part of the shift to value-based care. Here are 5 things to know about the final rule.

The cost of an intravenous drug used to treat lead poisoning has skyrocketed after a 2700% price increase by Valeant Pharmaceuticals. Experts worry that its high price and the lack of alternatives will place it out of reach for hospitals that need it. This is not the first time Valeant has been criticized for its price-raising practices.

A short online test evaluates respondents’ health status to determine their risk of having prediabetes. However, some doctors worry that too many people will fall into the high-risk category, contributing to an overuse of resources.

A study suggests that regions of England where patients show less awareness of cancer symptoms tend to have lower cancer survival rates, particularly in lower-income areas. The research, published in the British Journal of Cancer also examined whether barriers to care can affect the likelihood of surviving different cancers.

CMS announced on Thursday that it would award $347 million in contracts to various hospital associations and quality improvement organizations as part of its ongoing effort to reduce hospital-acquired conditions and readmissions in the Medicare program. The Hospital Improvement and Innovation Network agreement sets high goals in hopes of continuing the progress that has already been made in patient safety.



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo